Journal of Clinical Oncology

Reply to: Random Assignment, But Without Comparison: A Missed Opportunity

D Dewi Vernerey (Methodology and Quality of Life in Oncology Unit, Centre Hospitalier Universitaire de Besançon, Besançon, France) J Jean-Baptiste Bachet A Antonio Sa Cunha L Lilian Schwarz (Dewi Vernerey, PhD, Methodology and Quality of Life in Oncology Unit, Centre Hospitalier Universitaire de Besançon, Besançon, France, Université Marie et Louis Pasteur, EFS, INSERM UMR1098 RIGHT, Besançon, France; Jean-Baptiste Bachet, MD, PhD, Sorbonne University, Hepatogastroenterology and Digestive Oncology Department, Pitié Salpêtrière Hospital, APHP, Paris, France; Antonio Sa Cunha, MD, PhD, Paris Saclay University, Centre Hépato-Biliaire, Department of HPB Surgery and Transplantation, Paul Brousse Hospital, APHP, Villejuif, France; and Lilian Schwarz, MD, PhD, Rouen University Hospital, Department of Digestive Surgery, Rouen, France, Normandie University, UNIROUEN, UMR 1245 INSERM, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, Rouen, France)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 25
Published September 01, 2025
Pages 2837-2839
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (4)

D

Dewi Vernerey

Methodology and Quality of Life in Oncology Unit, Centre Hospitalier Universitaire de Besançon, Besançon, France

J

Jean-Baptiste Bachet

A

Antonio Sa Cunha

L

Lilian Schwarz

Dewi Vernerey, PhD, Methodology and Quality of Life in Oncology Unit, Centre Hospitalier Universitaire de Besançon, Besançon, France, Université Marie et Louis Pasteur, EFS, INSERM UMR1098 RIGHT, Besançon, France; Jean-Baptiste Bachet, MD, PhD, Sorbonne University, Hepatogastroenterology and Digestive Oncology Department, Pitié Salpêtrière Hospital, APHP, Paris, France; Antonio Sa Cunha, MD, PhD, Paris Saclay University, Centre Hépato-Biliaire, Department of HPB Surgery and Transplantation, Paul Brousse Hospital, APHP, Villejuif, France; and Lilian Schwarz, MD, PhD, Rouen University Hospital, Department of Digestive Surgery, Rouen, France, Normandie University, UNIROUEN, UMR 1245 INSERM, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, Rouen, France

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001